Laparoscopic cholecystectomy in the elderly.

Surg Endosc

Department of Surgery, Temple University/Conemaugh Memorial Medical Center, Johnstown, PA 15905, USA.

Published: January 1996

Background: Few studies have examined the results of laparoscopic cholecystectomy (LC) in the elderly. We reviewed our experience with the procedure in 194 patients age 65 and older.

Methods: A chart review was performed on patients who underwent attempted LC over a 4-year period. Age, conversion rate to open cholecystectomy (OC), length of stay, and morbidity and mortality rates were compared between elective and inpatients as well as between patients age 65-75 and patients over age 75.

Results: Conversion rate to OC was 10.6%. Mean length of hospital stay was 2.7 days. Morbidity and mortality rates were 18% and 1%. Elective patients experienced significantly fewer medical complications. There were no differences in complication rates between patients age 65-75 and patients over 75 years, but younger patients had a significantly shorter mean length of hospitalization.

Conclusions: Elderly patients experience more complications and longer lengths of stay than the general population. However, our results compare favorably with OC series in elderly patients.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s004649910007DOI Listing

Publication Analysis

Top Keywords

patients age
16
patients
10
laparoscopic cholecystectomy
8
cholecystectomy elderly
8
conversion rate
8
morbidity mortality
8
mortality rates
8
age 65-75
8
65-75 patients
8
elderly patients
8

Similar Publications

Aim: The aim of this study is to investigate the effect of obesity on the treatment outcomes of lumbar transforaminal epidural steroid injections (TFESIs).

Material And Methods: This retrospective study included patients who underwent single-level TFESI in a pain management center between January 2021 and April 2023. Body mass index (BMI) of the patients was evaluated based on the World Health Organization guidelines.

View Article and Find Full Text PDF

Aim: The aim of this retrospective study was to investigate the morphology of sella turcica (ST) in Chiari malformation type I (CM-I) using computed tomography.

Material And Methods: The size and shape of ST were examined using the radiological images of 32 CM-I patients (21 women/11 men, mean age: 26.09 ± 15.

View Article and Find Full Text PDF

A Homozygous Variant in HSD17B1 Identified in Women With Poor Ovarian Response.

Clin Genet

January 2025

NHC Key Laboratory of Human Stem Cell and Reproductive Engineering, School of Basic Medical Sciences, Central South University, ChangSha, China.

An increasing number of patients utilizing in vitro fertilization (IVF) and assisted reproductive technology (ART) are characterized as impaired or poor ovarian responders (PORs). Owing to its unclear molecular etiology, the management of patients with age-related ovarian characteristics remains a controversial and complex clinical concern. Therefore, it is important to identify and understand the etiological causes behind POR to develop more effective and efficient management strategies for these patients.

View Article and Find Full Text PDF

Objective: To assess the association between prostate-specific antigen (PSA) density (PSAD) and prostate cancer mortality after a benign result on systematic transrectal ultrasonography (TRUS)-guided prostate biopsy.

Patients And Methods: This retrospective study used data from the Finnish Randomised Study of Screening for Prostate Cancer (FinRSPC) collected between 1996 and 2020. We identified men aged 55-71 years randomised to the screening arm with PSA ≥4.

View Article and Find Full Text PDF

Aims: Evaluate glycated haemoglobin (HbA1c) and weight changes after 6 months of once-weekly (QW) injectable glucagon-like peptide-1 receptor agonist (GLP-1 RA) therapy in UK primary care.

Materials And Methods: Retrospective, non-interventional study, using the Clinical Practice Research Datalink Aurum primary care database, identified adults with type 2 diabetes (T2D) newly initiating a QW injectable GLP-1 RA between January 2020 and November 2021. Dual primary outcomes were proportion of patients with (1) HbA1c < 7% (<53 mmol/mol) and (2) weight loss categories (from 0% to 15+%) after 6 months of continuous GLP-1 RA therapy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!